Significant association between renal function and amyloid-positive area in renal biopsy specimens in AL amyloidosis

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Kuroda, Takeshi ^a   Tanabe, Naohito ^b   Kobayashi, Daisuke ^a   Wada, Yoko ^a   Murakami, Shuichi ^a   Nakano, Masaaki ^c   Narita, Ichiei ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b UNIVERSITY OF NIIGATA PREFECTURE   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

AL amyloidosis; Amyloid positive area; Creatinine clearance; Estimated GFR; Renal function

Indexed keywords

ALBUMIN; AMYLOID; CREATININE; IMMUNOGLOBULIN; IMMUNOGLOBULIN LAMBDA CHAIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY PARENCHYMA; LIGHT CHAIN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE LINEAR REGRESSION ANALYSIS; PROTEIN BLOOD LEVEL; SEX; STATISTICAL ANALYSIS; TISSUE SECTION; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AMYLOID; AMYLOIDOSIS; BIOPSY; FEMALE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84866493036     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-118     Document Type: Article

References (25)

1. Nomenclature and classification of amyloid and amyloidosis. Husby G, J Intern Med 1992 232 511 512 10.1111/j.1365-2796.1992.tb00626.x 1474353
2. The systemic amyloidosis. Falk RH, Comenzo RL, Skinner M, N Engl J Med 1997 337 898 909 10.1056/NEJM199709253371306 9302305 (Pubitemid 27408573)
3. Cardiac amyloidosis. Kingman A, Pereira NL, JS C Med Assoc 2001 97 201 206
4. Neurologic complications of primary systemic amyloidosis. Kelly JJ, Rev Neurol Dis 2006 3 173 181 17224900 (Pubitemid 46034484)
5. Bilateral carpal tunnel syndrome as a clue for the diagnosis of systemic amyloidosis. Nestle FO, Burg G, Dermatology 2001 202 353 355 10.1159/000051681 11455159 (Pubitemid 32664541)
6. Primary systemic amyloidosis presenting as extensive cutaneous ulceration. Alhaddab M, Srolovitz H, Rosen N, J Cutan Med Surg 2006 10 253 256 17234110 (Pubitemid 351506639)
7. Plasma cell disorderes. Kyle RA, Cecil textbook of medicine, Glodman L, Bennett JC, 21st 2000 977 987
8. Primary systemic amyloidosis: resolution of the nephrotic syndrome with melphalan and prednisone. Kyle RA, Wagoner RD, Holley KE, Arch Intern Med 1982 142 1445 1447 10.1001/archinte.1982.00340210037009 7103624 (Pubitemid 12048341)
9. AL amyloidosis: therapeutic response in two patients with renal involvement. Goddard IR, Jackson R, Jones JM, Nephrol Dial Transplant 1991 6 592 594 10.1093/ndt/6.8.592 1956560
10. A trial of three regimens for primary amyloidosis: colchicines alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM, N Engl J Med 1997 336 1202 1207 10.1056/NEJM199704243361702 9110907 (Pubitemid 27183649)
11. Clinical outcome of immunogloburin light chain amyloidosis affecting the kidney. Gertz MA, Leung N, Lacy MQ, Dispenzieri A, Zeldenrust SR, Hayman SR, Buadi FK, Dingli D, Greipp PR, Kumar SK, Lust JA, Rajkumar SV, Russell SJ, Witzig TE, Nephrol Dial Transplant 2009 24 3132 3137 10.1093/ndt/gfp201 19403931
12. A proposed histopathologic classification, scoring, and grading system for renal amyloidosis: standardization of renal amyloid biopsy report. Sen S, Sarsik B, Arch Pathol Lab Med 2010 134 532 544 20367305
13. Modification of the modification of diet in renal disease (MDRD) study equation for Japan. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S, Am J Kidney Dis 2007 50 927 937 10.1053/j.ajkd.2007.09.004 18037093 (Pubitemid 350130278)
14. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in reactive amyloidosis associated with rheumatoid arthritis. Kuroda T, Tanabe N, Kobayashi D, Wada Y, Murakami S, Nakano M, Narita I, Rheumatol Int 2011 10.1007/s00296-011-2148-8
15. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Kyle RA, Gertz MA, Semin Hematol 1995 32 45 59 7878478 (Pubitemid 24370135)
16. The long-term prognosis of AA and AL renal amyloidosis and the pathogenesis of chronic renal failure in renal amyloidosis. Bohle A, Wehrmann M, Eissele R, Gise HV, Mackensen-Haen S, Muller C, Pathol Res Pract 1993 189 316 331 10.1016/S0344-0338(11)80516-9 8332574 (Pubitemid 23155662)
17. Prognosis of renal amyloidosis: a clinicopathological study using cluster analysis. Sasatomi Y, Kiyoshi Y, Uesugi N, Hisano S, Takebayashi S, Nephron 2001 87 42 49 10.1159/000045883 11174025 (Pubitemid 32171118)
18. Renal function at the time of renal biopsy as a predictor of prognosis in patients with primary AL-amyloidosis. Osawa Y, Kawamura K, Kondo D, Imai N, Ueno M, Nishi S, Iino N, Okada M, Suzuki Y, Hoshino S, Yamazaki H, Kishimoto H, Shimada H, Yamagishi T, Ishiyama T, Narita I, Gejyo F, Clin Exp Nephrol 2004 8 127 133 15235929 (Pubitemid 38899639)
19. Presentation and course of primary amyloidosis of the kidney. Ogg CS, Cameron JS, Williams DG, Turner DR, Clin Nephrol 1981 15 9 13 7214752 (Pubitemid 11184528)
20. Morphological and clinical features of renal amyloidosis. Watanabe T, Saniter T, Virchows Arch 1975 366 125 135
21. Morphological and clinical correlates in renal amyloidosis. Dikman SH, Churg J, Kahn T, Human Pathol 1981 12 360 369 10.1016/S0046-8177(81)80146-3 (Pubitemid 11112343)
22. Limitation of creatinine as a filtration marker in glomerulopathic patients. Shemesh O, Golbetz H, Kriss JP, Mayer BD, Kidney Int 1985 28 830 838 10.1038/ki.1985.205 2418254 (Pubitemid 16156326)
23. Collaborators developing the Japanese equation for estimated GFR. Rivised equation for estimated GFR from serum creatinine crearance in Japan. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Am J Kid Dis 2009 53 982 992 10.1053/j.ajkd.2008.12.034 19339088
24. Effective anti-TNF- therapy can Induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis. Kuroda T, Wada Y, Kobayashi D, Murakami S, Sakai T, Hirose S, Tanabe N, Saeki T, Nakano M, Narita I, J Rheumatol 2009 36 2409 2415 10.3899/jrheum.090101 19797512
25. Immunopathology group of the Italian society of nephrology. Renal involvement in systemic amyloidosis. Bergesio F, Ciciani AM, Manganaro M, Palladini G, Santostefano M, Brugnano R, Di Palma AM, Gallo M, Rosati A, Tosi PL, Salvadori M, Nephrol Dial Transplant 2008 23 941 951 17951308